ing the occurrence of myocardial ischemia in these patients as assessed by myocardial lactate metabolism and/or by the evaluation of left ventricular function. [4] [5] [6] [7] [8] [9] [10] [11] [12] Therefore, the link between chest pain and the ECG changes and the reduced coronary vasodilator reserve remains questionable.
Recently, a diminished myocardial perfusion reserve has been demonstrated in patients with normal or "near normal" coronary arteries using '"0-labeled water and dynamic positron emission tomography (PET).13 How- ever, the relation between coronary reserve and the ECG response during exercise stress was not explored by these authors.
In the present study, we have investigated the correlation between coronary perfusion reserve, as assessed by "N-labeled ammonia and PET, and the ECG response during exercise stress in 45 patients with chest pain and angiographically normal coronary arteries in an attempt to better understand the relation between myocardial perfusion, symptoms and ECG abnormalities.
Methods

Study Population
The study population consisted of 37 women and eight men (mean age, 52±8 years; range, 37-70 years) who were recruited on the basis of the following criteria: a history of chest pain, angiographically normal coronary arteries without minimal irregularities, and a negative ergonovine test (incremental doses from 0.025 to 0.20 mg i.v.) for both symptomatic and ECG criteria ( Table 1) .
The resting ECG was normal in 32 of 45 (71%) patients and showed nonspecific disturbances of ventricular repolarization (flat and low-voltage negative T waves) in (Table 1 ). The stress test was always performed within the 3 weeks preceding the flow study. A period of pharmacological washout of at least 72 hours was allowed before the study (no patient was on treatment with p-blockers before entering the study). The protocol of the study was approved by the local ethics committee. Each subject was informed of the investigative nature of the study, and written consent was obtained before entry.
Positron Emission Tomography
Regional myocardial blood flow was measured by means of "N-ammonia and dynamic PET.14,15 Baseline myocardial blood flow was measured in all 45 patients. In 43 of 45 patients, myocardial perfusion was also measured after an intravenous infusion of dipyridamole (0.56 mg/kg over 4 minutes). In two patients (15 and 38, Table 1 ), myocardial blood flow after dipyridamole could not be assessed because of the presence of asthma in the first case and for technical reasons in the second.
Three ECG leads (V2, V4, and V6) were continuously monitored during the study period, and a complete 12-lead ECG was recorded every minute during dipyridamole infusion and up to 10 minutes after the end of infusion. Blood pressure was measured every minute by a cuff sphygmomanometer during dipyridamole infusion and for 10 minutes thereafter. In 17 patients, including the two subjects in whom flow after dipyridamole infusion could not be assessed, myocardial blood flow was also measured during transesophageal atrial pacing with a tetrapolar catheter (MEDICO TOEC 4) and a high-output external pulse generator (Medtronic, model 2380). Atrial capture usually was achieved with a pulse width of 15 msec and an output of 10 mA.
The patient was positioned on the bed of the two-ring ECAT III positron tomograph (CTI, Knoxville, Tenn.)
(this machine provides three simultaneous sections, two from the primary planes and one from the interplane) so that the center of gravity of the left ventricle was as close as possible to the center of both the axial and transaxial fields of view. Before performing the emission study, a circular ring source filled with about 2 mCi of 'Ge was used for the blank and transmission data acquisition. A rectilinear transmission scan was used as a low-resolution x-ray film to identify the heart profile. Thereafter, the transmission scan was performed to measure the attenuation correction coefficients to be used for each line of response of the sinogram. The patient's position with respect to the camera was checked by a cross-shaped low-power laser beam and pen marks on the patient's skin. For each flow measurement, "N-ammonia (0.20-0.25 mCi/kg body wt), prepared as reported elsewhere,16 was slowly injected intravenously over a period of 15-20 seconds. Dynamic acquisition was started simultaneously with the beginning of the injection of the tracer, and a total of 28 frames (16x3, lix12, and 1x300 seconds) were acquired over 8 minutes. Blood flow during hyperemic conditions was assessed by injecting '3N-ammonia 4 minutes after the end of dipyridamole infusion or during maximal atrial pacing (injections were always performed at least 2 minutes after the maximal pacing rate was achieved). The rate-pressure product was calculated as heart rate multiplied by systolic blood pressure, and regional coronary resistance was calculated as mean arterial blood pressure divided by myocardial blood flow. Coronary reserve was calculated by dividing the myocardial blood flow achieved after dipyridamole infusion or during rapid pacing by the baseline blood flow.
Analysis of PET Data
The sinograms were normalized according to the tomograph disuniformity map, corrected for attenuation, and then reconstructed with a transaxial spatial resolution of about 9 mm (full width at half maximum). The sum of the rates of randoms and multiples related to each sinogram were used for dead-time loss corrections.17 A small region of interest, to minimize spillover from the wall and to avoid the partial volume effect, was drawn within the left ventricular cavity. The size and shape of the regions of interest were assessed on the last equilibrium scan. The time-activity curve was computed inside the region of interest in the left ventricular cavity, and data values then were corrected for decay and dead-time loss. To get an automatic edge detection of the left ventricular wall and calculate the tissue activity from the last 300-second frame, a dedicated computer program was developed. Six to eight (average size, 2.7±0.4 cm3) regions of interest encompassing the septum and the anterior and free walls of the left ventricle were drawn automatically in each tomogram.14 Mean left ventricular wall activity was calculated by averaging the counts of the different regions of interest. The coefficients of variation of mean counts in the three contiguous planes at rest, during pacing, and after dipyridamole infusion were calculated and found to be comparable. As a consequence, quantitative analysis of flow was performed in only one of the three planes at midventricular level. Regional myocardial blood flow 2, and 3, respectively), and after dipyridamole (10.2± 3.9, 11.5±4.6, and 11.7±4.4 for planes 1, 2, and 3, respectively).
Baseline Myocardial Blood Flow
At baseline, mean heart rate in the 45 patients was 72±12 beats per minute, systolic blood pressure was 130±19 mm Hg, and diastolic blood pressure was 82±9 mm Hg. Baseline flow values had a normal distribution and ranged from 0.61 to 1.54 ml -min-m. g-1 (Figure 1 ).
Mean resting left ventricular blood flow was 1.04±0.22 ml * min 1 . g-1. Flow in the interventricular septum was significantly higher than flow in the free and anterior walls of the left ventricle (Figure 2 
Myocardial Blood Flow After Dipyridamole Infusion
Mean heart rate after dipyridamole infusion increased to 101±16 beats per minute (p<0.01 versus baseline value). Systolic blood pressure was reduced to 125±20 mm Hg (p<0.01 versus baseline value), whereas diastolic blood pressure was not significantly different from baseline (80±9 mm Hg). Twenty-seven of 43 patients experienced chest pain after drug administration. Significant ST segment depression occurred after dipyridamole infusion in 24 of 43 patients; 19 of these also had associated chest pain (Table 1) . Mean left ventricular blood flow after dipyridamole increased significantly to 2.52±0.96 ml * min g`(p<0.01 versus baseline value). Coronary reserve (mean left ventricular flow after dipyridamole divided by mean flow at baseline) was 2.45 ±0.89. In addition, a significant correlation (r=0.60, p<0.05) existed between coronary reserve assessed with dipyridamole and that assessed with pacing ( Figure 3) . Flow in the interventricular septum was higher than flow in both the free wall and the anterior wall of left ventricle (Figure 2 ).
Frequency Distribution of Myocardial Flows After Dipyridamole Infusion
Myocardial flow rates after dipyridamole infusion did not show a normal distribution, as indicated by the Kolmogorov-Smirnov one-sample normality test. As shown in Figure 1 , the bimodal distribution of flow rates after dipyridamole infusion suggests the presence of two different patient populations. Therefore, a dividing point corresponding to the nadir of the frequency distribution was chosen (cutoff point at 2.10 mlmin-m g-1). According to this separation, 29 of 43 (67%) patients (high-flow group) had a mean left ventricular flow of 3.02±0.33 ml * minm g`after dipyridamole (range, 2.13-5.46 ml * min-l g-'), and 14 (33%) patients (low-flow group) had a mean left ventricular flow of 1.48±0.29 ml min-l g (range, 1.06-2.04 ml * min' g-';p<0.01 versus the high-flow group) (Figure 4) . The main characteristics of the two patient populations are summarized in Table 2 however, also had ST segment depression during exercise stress, whereas 13 of 29 patients did not ( Figure 5 , Table 3 ). Myocardial blood flow after dipyridamole was significantly lower in the 29 patients with ST depression during exercise stress than in the 16 patients without (2.18+0.75 versus 3.15±1.00 ml * min-1 * g-', p<0.01).
However, if patients were grouped on the basis of the presence or absence of chest pain alone during exercise stress or on the basis of chest pain and/or ST depression after dipyridamole (0.56 mg/kg) or during pacing, no significant differences in maximal flow and/or coronary vasodilator reserve could be demonstrated.
Discussion
The results of the present investigation, in agreement with previous reports,1"2'4 indicate that coronary vasodilator response to different stimuli is blunted in some patients with chest pain and normal coronary angiograms.
Regional Distribution of Myocardial Blood Flow
No differences in the coefficient of variation of counts among the three different tomographic planes could be demonstrated at baseline during pacing and after dipyridamole. There is no obvious explanation for the higher flow values observed in the interventricular septum as compared with the ventricular free wall. This occurred in both patient groups both at rest and after stress and might be related to different regional oxygen demands. Recently, regional differences in myocardial '3N-ammonia uptake in control subjects have been reported. 18 In no instance, however, were regional flow defects demonstrated in any of the patients at baseline or after stress. This is in agreement with previous observations by Geltman et al,13 whereas it is at variance with the high prevalence of positive`1lTl scans generally reported in these patients.19'20 Our PET data, however, were acquired in an ungated mode with consequent spatial averaging, and data were analyzed with large regions of interest on a small portion of left ventricular myocardium. Therefore, small regional flow abnormalities might have been missed. Another possible limitation of our study may derive from the algorithm used to correct for the decrease of ammonia extraction with increasing flow rates, which was obtained from experiments in dogs.14 No differences could be found between these two groups in terms of age or hemodynamic parameters except for a higher rate-pressure product after dipyridamole infusion in the group with higher flow rates. In an attempt to verify whether the differences in maximal flow could be accounted for by a different oxygen demand, the flow rates were corrected for their relative rate-pressure products. Even after this correction, however, myocardial flows in the two patient groups remained statistically different (Table 2) . It is worth noting that these two groups also had significantly different baseline myocardial blood flows despite similar baseline rate-pressure products. The patients with a blunted flow response to dipyridamole had a baseline Patients are grouped according to their absolute flow response after dipyridamole (see Figures 1 and 4) . Patients' numbers are the same as in Table 1 . Coronary reserve, dipyridamole/baseline myocardial blood flow; positive (+) ECG exercise, ST depression during stress; negative (-) ECG exercise, no ST depression during stress (see Table 1 ). flow of 0.88+±0.13 ml* min-l . g-', which is similar to that recently reported in normal subjects by Araujo et a122 (0.84±0.09 ml* min-m . g-') using '5O-labeled water and by Krivokapich et at24 (0.75+±0.43 ml* min-l g-') using 13N-ammonia. Patients with a good flow response to dipyridamole had a significantly higher resting myocardial flow: 1.12±0.13 ml * min-1 * g-', a figure comparable to that measured by Geltman et the group with a blunted coronary flow response after dipyridamole infusion. Therefore, the majority of patients with ischemic-like changes on the ECG during exercise had a preserved coronary vasodilator response. In addition, no correlation could be found between coronary vasodilator reserve and the presence or absence of chest pain and/or ST depression after dipyridamole infusion. It is, therefore, reasonable to assume that factors other than myocardial ischemia may play a role in determining the symptoms and ECG changes in these patients. In support of this hypothesis, no metabolic evidence of myocardial ischemia could be demonstrated in patients with syndrome X (a term commonly used to identify patients with chest pain, angiographically normal coronary arteries, and ischemic-like changes on the ECG during exercise) during pacinginduced chest pain and ST segment depression.4 Therefore, although the presence of ischemic-like changes in the ECG during exercise seems to be a sensitive marker to identify patients with a blunted increment of coronary flow after dipyridamole infusion, its specificity is very low. Accordingly, in our series, the probability of finding a reduced flow response after dipyridamole among patients without ECG changes during exercise was quite low.
Possible Mechanisms Responsible for Impairment of Coronary Reserve
Cannon and Epstein2,3 have proposed that dysfunction of small intramural prearteriolar coronary arteries might be the cause of the reduced flow reserve in patients with chest pain and normal coronary arteries. It is worth noting that in the absence of atherosclerotic disease of large epicardial arteries, almost all coronary resistance is located in the microcirculation. According to Chilian et al,25 a significant proportion (40-50%) of total coronary resistance resides in arterioles greater than 100 ,m. Furthermore, there is evidence for adrenergically mediated vasoregulation in coronary arterioles with a resting diameter greater than 100 ,um in which the presence of both al-and a2-adrenergic receptors have been demonstrated. 26 Recently, we have reported a reduced coronary vasodilator reserve during atrial pacing in a group of patients with syndrome X in whom metabolic and functional evidence of increased sympathetic drive also could be demonstrated. 4 Therefore, it can be hypothesized that the impairment of coronary vasodilator reserve might be, at least in part, an adrenergically mediated phenomenon, probably through activation of a-adrenoceptors on coronary arterioles. This is in agreement with the results of a preliminary study from our group in which the selective al-blocker doxazosin was shown to be effective in improving coronary reserve in patients with chest pain and normal coronary angiograms. 27 In addition, it has been demonstrated that adrenergic vasoconstriction can oppose metabolic coronary vasodilation during exercise in normal dogs and that the nonselective a-adrenergic blockade with phentolamine is able to produce an increase in coronary flow during exercise. 28 The phenomenon is more pronounced in hypertensive animals with left ventricular hypertrophy and is even more affected by a-adrenergic blockade.29 It is worth noting that, although no difference in both systolic and diastolic pressures could be found between the patients in the low-flow group and those in the high-flow group, patients with borderline and established arterial hypertension (n = 11) had a lower but not statistically significant coronary reserve than normoten-sive patients (2.05+0.42 versus 2.59+0.98, p=0.09). Obviously, other factors, such as a pathological growth of vascular smooth muscle, which would alter the vascular lumen-to-wall ratio,30 may play a role in sustaining these microvascular disturbances.
Conclusions
The results of our study show that a blunted coronary reserve can be demonstrated in approximately 30% of patients with chest pain and normal coronary arteries. A stress test positive for ECG criteria is a sensitive tool to identify those patients with a blunted coronary reserve, although its specificity is very low.
Different from single-photon tomography with 20`T1 or SESTAMIBI, which does not allow measurement of absolute myocardial blood flow, PET appears to be a safe, cost-effective test to detect those patients in whom coronary flow reserve is diffusely blunted.
